To evaluate the clinical effectiveness of thermalytix for screening breast cancer in women above 18 years.
Symptomatic and asymptomatic women aged 18 years and above
Exclusion: Pregnant and lactating women, women with known history of breast cancer, and those who have undergone lumpectomy and mastectomy.
Thermalytix is an automated breast screening solution based on artificial intelligence used for detection and localization of malignant breast tissue lesions. It can be used for screening both symptomatic and asymptomatic women aged above 18 years.
Mammography: Specific type of imaging of breasts that uses low doses of X- rays for the early detection of cancer and other breast diseases.
Clinical Breast Examination: Clinical examination of the breast performed by a trained health professional
Primary outcomes: Mortality
Secondary outcomes: ICER and DALYs averted (Cost-effectiveness)